Medtronic 770G added to Insulin Pump Program
The Medtronic Minimed 770G will be added to the Federal Governments Insulin Pump Program – a significant step toward achieving our goal of more technology for more people through our policy agenda.
So, what does this mean for you?
The IPP provides insulin pumps to families who have children under 18 years of age with type 1 diabetes (T1D) and meet the financial and clinical eligibility requirements. You can read more about the Insulin Pump Program here.
If you would like to apply for the JDRF Insulin Pump Program, you can visit pumps.jdrf.org.au.
The department has listened to our calls for newer technologies to be made available for families who would not otherwise be able to access an insulin pump.
You can read more about the Medtronic 770G on the Medtronic website.
Unfortunately there is no avenue to upgrade current pumps. Families will be able to apply for an upgrade at the end of their current warranty period.
The application process and eligibility criteria remain the same. Pump choice is made in consultation between families and their treating diabetes team.
The Insulin Pump Program will be in contact with your diabetes team.
JDRF welcomes TGA approval on Pfizer vaccine for children aged 12-15
JDRF Australia welcomes the announcement that the Therapeutic Goods Administration (TGA) has approved the Pfizer COVID-19 vaccine for children aged 12-15. We look forward to the final decision from the Australian Technical Advisory Group on Immunisation (ATAGI) to prioritise children with underlying conditions, including type 1 diabetes, and include them immediately in the vaccine rollout. […]
JDRF welcomes leading medical researcher to Board to support continued research excellence
JDRF Australia are delighted to welcome Professor Fabienne Mackay to the Board of JDRF Australia. Professor Mackay, who joined the Board at the June 2021 Board meeting, will also play an important role on JDRF’s Board Research Committee, evaluating and ensuring JDRF continues to support the best local research into type 1 diabetes (T1D). Prof. Mackay obtained her PhD from Louis Pasteur University in Strasbourg, France and has more than […]
New Science Accelerator Grants Awarded to Early-Mid Career Researchers
JDRF and The Leona M. and Harry B. Helmsley Charitable Trust are excited to announce more than $1.2 million in new funding for three outstanding early-mid career Australian researchers. The ENDIA Early-Mid Career Science Accelerator Awards will support the researchers in carrying out new projects using samples collected as part of the ENDIA study, the […]
T1D Research Roundup: June 2021
Our research roundups bring you the most exciting T1D research stories from around the world – the new advances in treatment, devices and knowledge that are making the biggest impact in the fight to cure, treat and prevent T1D. This month, the American Diabetes Association held their 81st Scientific Sessions. The world’s top type 1 […]